
Ep. 338 From Numbers to Decisions: Clinical Utility of Biomarkers in Prostate Cancer Diagnosis with Dr. Amir Lebastchi
Every prostate cancer biomarker returns a number, but the real question is whether that number changes what you do next for the patient. On this episode of BackTable Urology, Dr. Ruchika Talwar welcomes Dr. Amir Lebastchi, urologic oncologist at Keck Medicine of USC, to discuss how biomarkers are moving prostate cancer care from numbers to meaningful clinical decisions. They define what makes a biomarker clinically useful, organize the growing list of blood, urine, and tissue tests into pre-biopsy, post-negative-biopsy, and post-diagnosis settings, and talk through where these tests fit alongside MRI after an elevated PSA.
Publisher
BackTable Urology
Published
October 27, 2026
Duration
49 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
BackTable Inc.
BackTable Urology
@backtableurology
#clinicalutility #prostatecancerdiagnosis #amirlebastchi #medicine
